Related Experiment Video
Updated: Apr 16, 2026
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
[Caspase-independent programmed cell death induced by temozolomide in rat glioma C6 cell line]
1Department of Neurology, First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi'an 710061, China.E-mail: chinaylh2003@163.com.
Objective:
To investigate programmed cell death induced by temozolomide in rat glioma C6 cell line.
Methods:
Rat glioma C6 cell line was treated by temozolomide at different concentrations and for different time lengths. MTT assay was used to evaluate the cell inhibition rate to determine the optimal exposure time and concentration. After the exposure to 400 µg/ml temozolomide for 24 h, the cells were observed for programmed cell death using HE staining, Hochest and Tunnel assay, Western blotting, and immunohistochemistry.
Results:
MTT, HE staining, and Hochest and Tunnel assay all showed temozolomide-induced apoptosis in rat glioma C6 cell line. Western blotting and immunohistochemistry revealed up-regulation of Bax and down-regulation of Bcl-2 expression in the exposed cells, where the expressions of caspases 3, 8, 9, and 12 remained unchanged.
Conclusion:
Temozolomide induces apoptosis in rat glioma C6 cell line through a caspase- independent pathway.
Related Concept Videos
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
01:24Caspases